-
Innovation Ranking
NewInnovation Ranking – AIM ImmunoTech Inc
AIM ImmunoTech Inc (AIM ImmunoTech), formerly Hemispherx Biopharma Inc, is an immuno- pharma company. The company focuses on the research and development of therapeutics for the treatment of multiple types of cancers, viruses and immune-deficiency disorders. Its flagship products include Ampligen (rintatolimod) sterile solution which is indicated for the treatment of patients with chronic fatigue syndrome; and Alferon N Injection used for the treatment of refractory or recurrent external condylomata acuminate. The company’s pipeline products are intended to treat various...
-
Product Insights
NewNet Present Value Model: AIM ImmunoTech Inc’s Ampligen
Empower your strategies with our Net Present Value Model: AIM ImmunoTech Inc's Ampligen report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
AIMS AA REIT Solar PV Park
AIMS AA REIT Solar PV Park is a solar PV project located in Singapore. The project is being developed by SP Group. The project is at the permitting stage. Empower your strategies with our AIMS AA REIT Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Company Insights
NewWorldline – Competitor Profile
Worldline Group is one of the world’s leading payment and transactional service providers, offering end-to-end solutions covering the entire payment value chain. It has omnichannel solutions for merchants, banks, acquirers, payment services providers (PSPs), businesses, and governments. Worldline operates its services in 170 countries, supporting payments in 140 currencies. Worldline operates through three segments—Merchant Services, Financial Services, and Mobility & e-Transactional Services—offering acquiring and processing, card issuing processing, clearing and settlement, open banking, and mobile banking services. Previously, it had...
-
Thematic Analysis
NewNet Zero Strategies in Aerospace, Defense, and Security – Thematic Intelligence
Net Zero Strategies in Aerospace, Defense, and Security Thematic Overview Net zero means cutting greenhouse gas emissions (GHG) to as close to zero as possible. Any remaining emission is then ‘offset.’ Firms that achieve net zero emissions are called “carbon neutral.” Companies are under pressure to cut emissions as countries aim to achieve their climate commitments. Primarily, they aim to achieve net zero operations by reducing their Scope 1 and 2 emissions and purchasing offsets. Most airline emissions fall under the...
-
Product Insights
NewLikelihood of Approval Analysis for Myelofibrosis
Overview How likely is it that the drugs in Myelofibrosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Myelofibrosis Overview Myelofibrosis is a rare bone marrow disorder where abnormal cells cause...
-
Product Insights
NewLikelihood of Approval Analysis for Pulmonary Tuberculosis
Overview How likely is it that the drugs in Pulmonary Tuberculosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pulmonary Tuberculosis Overview Pulmonary tuberculosis (TB) is an infectious respiratory disease caused...
-
Product Insights
NewLikelihood of Approval Analysis for Mucopolysaccharidosis
Overview How likely is it that the drugs in Mucopolysaccharidosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mucopolysaccharidosis Overview Mucopolysaccharidosis (MPS) refers to a group of inherited metabolic disorders causing...
-
Product Insights
NewLikelihood of Approval Analysis for Musculoskeletal Inflammation
Overview How likely is it that the drugs in Musculoskeletal Inflammation will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Musculoskeletal Inflammation Overview Musculoskeletal inflammation refers to the body's response to irritation,...
-
Product Insights
NewLikelihood of Approval Analysis for Bone Metastasis
Overview How likely is it that the drugs in Bone Metastasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bone Metastasis Overview Bone metastasis occurs when cancer cells spread from their...